Literature DB >> 32254257

Nanoscale metal-organic frameworks for drug delivery: a conventional platform with new promise.

Lei Wang1, Min Zheng, Zhigang Xie.   

Abstract

Development of a controllable drug delivery system is imperative and important to reduce the side-effects and enhance the therapeutic efficacy of drugs. Metal-organic frameworks (MOFs) and nanoscale MOFs (NMOFs), as porous hybrids constructed by polydentate bridging ligands and metal-connecting nodes, have attracted significant attention from the scientific community due to their tailorable compositions and structures, excellent porosity, and easier surface modification. Significant progress has been achieved in the past decade, but most attempts still remain in the proof-of-concept stage. This review highlights the latest advances in NMOFs for drug delivery systems and classifies the current drug-loading method into three strategies according to the location of the cargos and cargo-carrier interactions: encapsulation strategy, direct assembly strategy, and post-synthesis strategy. Each feature and the latest advances in these strategies are highlighted. Finally, the challenges and future perspectives in this field have been discussed.

Entities:  

Year:  2018        PMID: 32254257     DOI: 10.1039/c7tb02970e

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  31 in total

1.  Molecular simulations of the adsorption and separation of hydrogen sulfide, carbon dioxide, methane, and nitrogen and their binary mixtures (H2S/CH4), (CO2/CH4) on NUM-3a metal-organic frameworks.

Authors:  Azita Amouzad Khalili; Saeid Yeganegi
Journal:  J Mol Model       Date:  2021-04-24       Impact factor: 1.810

2.  Cu-BTC metal-organic framework as a biocompatible nanoporous carrier for chlorhexidine antibacterial agent.

Authors:  Sajjad Soltani; Kamran Akhbari
Journal:  J Biol Inorg Chem       Date:  2021-10-30       Impact factor: 3.358

3.  Nitric oxide detection using catalytic properties of CuCo-PTC metal organic framework.

Authors:  Meng Wang; Hui Dong; Yintang Zhang; Xu Zhu; Mengjiao Gu; Qianqian Zhu; Xing Miao; Yanli Zhou; Maotian Xu
Journal:  Mikrochim Acta       Date:  2022-07-01       Impact factor: 6.408

Review 4.  Applications of Metal-Organic Frameworks as Drug Delivery Systems.

Authors:  Bianca Maranescu; Aurelia Visa
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

5.  Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose.

Authors:  Wen Yang; Hanitrarimalala Veroniaina; Xiaole Qi; Pengyu Chen; Feng Li; Pu Chun Ke
Journal:  Adv Ther (Weinh)       Date:  2019-10-16

Review 6.  Hybrid Nanosystems for Biomedical Applications.

Authors:  Joshua Seaberg; Hossein Montazerian; Md Nazir Hossen; Resham Bhattacharya; Ali Khademhosseini; Priyabrata Mukherjee
Journal:  ACS Nano       Date:  2021-01-26       Impact factor: 18.027

7.  Thiosemicarbazone modified zeolitic imidazolate framework (TSC-ZIF) for mercury(ii) removal from water.

Authors:  Amani Jaafar; Carlos Platas-Iglesias; Rana A Bilbeisi
Journal:  RSC Adv       Date:  2021-04-30       Impact factor: 4.036

8.  Biomimetic nanoscale metal-organic framework harnesses hypoxia for effective cancer radiotherapy and immunotherapy.

Authors:  Kaiyuan Ni; Guangxu Lan; Yang Song; Ziyang Hao; Wenbin Lin
Journal:  Chem Sci       Date:  2020-04-20       Impact factor: 9.825

9.  Biocompatible metal-organic frameworks for the storage and therapeutic delivery of hydrogen sulfide.

Authors:  Faith E Chen; Ruth M Mandel; Joshua J Woods; Jung-Hoon Lee; Jaehwan Kim; Jesse H Hsu; José J Fuentes-Rivera; Justin J Wilson; Phillip J Milner
Journal:  Chem Sci       Date:  2021-04-30       Impact factor: 9.969

Review 10.  Degradation of Drug Delivery Nanocarriers and Payload Release: A Review of Physical Methods for Tracing Nanocarrier Biological Fate.

Authors:  Patrick M Perrigue; Richard A Murray; Angelika Mielcarek; Agata Henschke; Sergio E Moya
Journal:  Pharmaceutics       Date:  2021-05-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.